SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 16
|
records per page:
next > | last >>
|
SESSION INTRODUCTION
Risa M. Hoffman
David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA
CHANGES IN BONE MINERAL DURING AND AFTER LACTATION IN UGANDAN WOMEN ON OPTION B+ ART
(ABSTRACT
768)
Mary Glenn Fowler
Johns Hopkins University, Baltimore, MD, USA
POSTPARTUM WEIGHT CHANGES IN WOMEN INITIATING DTG VS EFV IN PREGNANCY: DOLPHIN-2
(ABSTRACT
771)
Thokozile Rosemary Malaba
University of Cape Town, Cape Town, South Africa
DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ
(ABSTRACT
772)
Jennifer Jao
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
FACTORS ASSOCIATED WITH GESTATIONAL DIABETES IN HIV+ AND HIV– WOMEN IN PUNE, INDIA
(ABSTRACT
774)
Puja Chebrolu
Weill Cornell Medicine, Columbus, GA, USA
HIGH BLOOD PRESSURE AND ADVERSE BIRTH OUTCOMES IN HIV+ AND HIV– SOUTH AFRICAN WOMEN
(ABSTRACT
769)
Angela Bengtson
Brown University, Providence, RI, USA
SESSION INTRODUCTION
Markella V Zanni
Massachusetts General Hospital, Boston, MA, USA
TESTOSTERONE THERAPY AND SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AMONG MEN WITH HIV
(ABSTRACT
642)
Sabina A. Haberlen
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
POSTDISCHARGE OUTCOMES FOLLOWING ACUTE CORONARY SYNDROME IN HIV
(ABSTRACT
643)
Monica Parks
University of California San Francisco, San Francisco, CA, USA
INSOMNIA AND RISK OF INCIDENT MYOCARDIAL INFARCTION AMONG PEOPLE LIVING WITH HIV
(ABSTRACT
644)
Bridget M Whitney
University of Washington, Seattle, WA, USA
HORMONE USE AND HIV ALTER CARDIOVASCULAR BIOMARKER PROFILES IN TRANSGENDER WOMEN
(ABSTRACT
645)
Jordan E Lake
University of Texas Health Science Center Houston, Houston, TX, USA
HIV SEVERITY AND INCIDENT HEART FAILURE AMONG PATIENTS IN A LARGE HEALTH CARE SYSTEM
(ABSTRACT
646)
Jennifer O. Lam
Kaiser Permanente, Oakland, CA, USA
SESSION INTRODUCTION
Rachel Baggaley
World Health Organization, Geneva, Switzerland
ASSISTED PARTNER NOTIFICATION SERVICES IN KAMPALA, UGANDA
(ABSTRACT
937)
Florence Namimbi
Infectious Diseases Institute, Kampala, Uganda
TARGETED PEER MOBILISATION AND ASSISTED PARTNER NOTIFICATION SERVICES IN KENYA
(ABSTRACT
938)
Maartje Dijkstra
Public Health Service Amsterdam, Amsterdam, NE, Netherlands
SCALE-UP OF ASSISTED PARTNER SERVICES (APS) IN BOTSWANA
(ABSTRACT
939)
Matthew R Golden
University of Washington, Seattle, WA, USA
OPTIMIZING TESTING INCREASES YIELD IN HIV CASE FINDING IN 24 COUNTRIES, 2018–2019
(ABSTRACT
940)
Shahul Hameed Ebrahim
Centers for Disease Control, atlanta, GA, USA
COMPARISON OF INDEX TESTING APPROACHES TO IMPROVE HIV-TESTING EFFICIENCY IN RWANDA
(ABSTRACT
942)
Eric Remera
RWANDA BIOMEDICAL CENTRE, kigali, Rwanda
ASSOCIATION BETWEEN TIME TO ART AND LOSS TO CARE AMONG NEWLY DIAGNOSED PLWH IN RWANDA
(ABSTRACT
1071)
Jonathan Ross
Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, USA
SAME-DAY ART IN THAILAND: THE IMPACT OF ART INITIATION PERIODS ON TREATMENT OUTCOMES
(ABSTRACT
1072)
Pich Seekaew
Columbia University, New York, NY, USA
RAPID START LEADS TO SUSTAINED VIRAL SUPPRESSION IN YOUNG PEOPLE IN THE SOUTH
(ABSTRACT
1073)
Jason Halperin
CrescentCare, New Orleans, LA, USA
ASSESSMENT OF IMMEDIATE INITIATION OF ANTIRETROVIAL THERAPY IN NEW YORK CITY
(ABSTRACT
1069)
Daniel Bertolino
New York City Department of Health and Mental Hygiene, Queens, NY, USA
SESSION INTRODUCTION
Alan N. Engelman
Dana-Farber Cancer Institute, Boston, MA, USA
HIV-1 CAPSID-NUCLEAR ENVELOPE INTERACTIONS THAT FACILITATE NUCLEAR IMPORT
(ABSTRACT
165)
Mohamed Husen Munshi
National Cancer Institute, Frederick, MD, USA
REPORTER VIRUSES WITH PROTEIN BARCODES TO ANALYZE HIV LATENCY ESTABLISHMENT
(ABSTRACT
166)
Eun Hye Grace Kim
Icahn School of Medicine at Mt Sinai, New York, NY, USA
GAG DETERMINANTS OF SPECIFIC GENOME PACKAGING IN HIV-1 AND HIV-2
(ABSTRACT
167)
Jonathan Rawson
National Cancer Institute, Frederick, MD, USA
EXPLORING THE REQUIREMENTS FOR HIV-1 GENOME PACKAGING THROUGH A NONVIRAL RNA BINDING
(ABSTRACT
168)
Alice Duchon
National Cancer Institute, FREDERICK, MD, USA
SESSION INTRODUCTION
Avindra Nath
National Institutes of Health, Bethesda, MD, USA
CONSERVED CSF HIV ANTIBODY RESPONSE IN PATIENTS WITH DIVERSE NEUROLOGIC PHENOTYPES
(ABSTRACT
405)
Isobel Anne Hawes
University of California San Francisco, San Francisco, CA, USA
CNS HIV BEARS ENVELOPE MARKERS CONSISTENT WITH T-CELL ORIGIN IN THE FACE OF ART
(ABSTRACT
424)
Alex Sigal
Africa Health Research Institute (AHRI), Durban, KwaZulu-Natal, South Africa
RETINAL THINNING CORRELATES WITH BRAIN ATROPHY IN WELL-CONTROLLED HIV INFECTION
(ABSTRACT
418)
Bryan Smith
National institutes of Health, Bethesda, MD, USA
BIOMARKERS OF NUCLEIC ACID OXIDATION AND NEURODEGENERATION IN CSF IN PWH
(ABSTRACT
411)
Ronald J. Ellis
University of California, San Diego, CA, USA
PREDICTIVE VALIDATION OF AN UGANDAN INFANT EYE-TRACKING TEST OF MEMORY OF HUMAN FACES
(ABSTRACT
412)
Michael Joseph Boivin
Michigan State University, East Lansing, MI, USA
SESSION INTRODUCTION
Sari L Reisner
Harvard T.H. Chan School of Public Health, Boston, MA, USA
PREEXPOSURE PROPHYLAXIS ADHERENCE AND PERSISTENCE IN KENYAN TRANSGENDER WOMEN AND MSM
(ABSTRACT
878)
Makobu Kimani
Kenya Medical Research Institute (KEMRI), Kilifi, Kenya
HIV PREVALENCE AND RISK IN MALE‚ TRANSMALE, AND TRANSFEMALE SEX WORKERS IN ZIMBABWE
Jan Anton Charles Hontelez
Erasmus University Medical Center, Rotterdam, Netherlands
FACTORS ASSOCIATED WITH HIV, HCV, AND HSV-2 SEROSTATUS AMONG US TRANSGENDER WOMEN
(ABSTRACT
880)
Morgan P Keruly
NIH, Baltimore, MD, USA
HIV PREVALENCE AMONG TRANSGENDER MEN AT AN NYC COMMUNITY HEALTH CENTER
(ABSTRACT
881)
Asa Radix
Callen-Lorde Community Health Center, New York, NY, USA
PROGRESSION THROUGH THE HIV CARE CONTINUUM FOR TRANSGENDER WOMEN IN THE NA-ACCORD
(ABSTRACT
882)
Catherine R Lesko
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
SESSION INTRODUCTION
Pablo Tebas
University of Pennsylvania, Philadelphia, PA, USA
EFFECT OF TAMOXIFEN ON VORINOSTAT-INDUCED HIV RNA EXPRESSION IN WOMEN ON ART (A5366)
(ABSTRACT
333)
Eileen P Scully
Johns Hopkins University, Baltimore, MD, USA
EFFECTS OF IMMUNE CHECKPOINT THERAPY ON LATENT HIV IN PEOPLE WITH HIV AND MALIGNANCY
(ABSTRACT
334)
Jillian SY Lau
Alfred Hospital, Glen Iris, VIC, Australia
ABX464 DECREASES THE TOTAL HIV RESERVOIR AND HIV TRANSCRIPTION INITIATION IN VIVO
(ABSTRACT
335)
Sara Moron-Lopez
University of California San Francisco - SFVAMC - NCIRE, San Francisco, CA, USA
ATTACKING LATENT HIV WITH CONVERTIBLE CAR-T CELLS, A MODULAR KILLING PLATFORM
(ABSTRACT
336)
Eytan Herzig
University of California San Francisco, San Francisco, CA, USA
CAR-T CELLS AT 15 YEARS: PERSISTENCE OF CD4-ZETA TRANSGENE AND EFFECT ON RESERVOIR
(ABSTRACT
337)
Naomi E Aronson
Uniformed Services University, Bethesda, MD, USA
SESSION INTRODUCTION
Jacqueline Capeau
Sorbonne University, PARIS, France
FAT GAINS OCCUR AFTER ART WITHOUT CHANGES IN METABOLIC RATE OR CALORIC INTAKE
(ABSTRACT
667)
Allison Ross Eckard
Medical University of South Carolina, Charleston, SC, USA
GREATER WEIGHT GAIN AFTER SWITCH TO INSTI-BASED REGIMEN FROM NNRTI VS PI REGIMENS
(ABSTRACT
668)
John Koethe
Vanderbilt University Medical Center, Nashville, TN, USA
BODY COMPOSITION CHANGES OVER THE MENOPAUSAL TRANSITION IN HIV+ AND HIV– WOMEN
(ABSTRACT
669)
Phyllis Tien
UCSF, San Francisco, CA, USA
|
<< first | < prev
page:
of 16
|
records per page:
next > | last >>
|
